Uterine Fibroids News and Research

Latest Uterine Fibroids News and Research

AMA establishes new CPT code for RF Ablation of Uterine Fibroids

Halt Medical is very pleased to announce that the American Medical Association Current Procedure Terminology Panel has established a new CPT code specifically for Radiofrequency Ablation of Uterine Fibroids.

10 Jul 2013

MRIgFU ablation therapy reduces pain in 67% of patients with bone tumors

Patients with cancer that has spread to their bones are often treated with radiation therapy to reduce pain. But if that treatment doesn't work, or can't be used again, a second, effective option now exists.

3 Jun 2013

Non-invasive brain surgery: an interview with Dr Andres Lozano, University of Toronto

MR-guided focused ultrasound is a new technique that involves focusing 1024 beams of ultrasound through the skull to a focal point in the brain, very much like using the sun and a magnifying glass to burn a hole in a sheet of paper.

22 Apr 2013

Women with sufficient amounts of vitamin D less likely to develop uterine fibroids

Women who had sufficient amounts of vitamin D were 32 percent less likely to develop fibroids than women with insufficient vitamin D, according to a study from researchers at the National Institutes of Health.

16 Apr 2013

Halt Medical reveals initial commercialization results, additional launch plans for Acessa System

Halt Medical, Inc. announced today initial commercialization results for the Acessa System and additional launch plans.

1 Apr 2013

Neurocrine Biosciences starts elagolix Phase IIb clinical trial for treatment of uterine fibroids

Neurocrine Biosciences, Inc. today announced that a Phase IIb clinical trial to evaluate elagolix for the treatment of uterine fibroids has been initiated.

27 Mar 2013

Neurocrine Biosciences fourth quarter net income increases to $9.5 million

Neurocrine Biosciences, Inc. today announced its financial results for the quarter and year ended December 31, 2012.

9 Feb 2013

African-American women who reported childhood abuse had greater risk of uterine fibroids

According to a new study from the Slone Epidemiology Center (SEC) at Boston University, African-American women who reported sexual or physical abuse before age 11 had a greater risk of uterine fibroids in adulthood compared with women who had no such abuse history.

25 Jan 2013

Halt Medical receives $15M financing for commercialization of Acessa uterine fibroid treatment system

Halt Medical, Inc. announced today that it has received $15 million of financing to support commercialization of the Acessa System, a newly FDA cleared medical device to treat uterine fibroids.

2 Jan 2013

EC grants CE mark to InSightec’s ExAblate Neuro ultrasound system

InSightec Ltd. announced that its transcranial focused ultrasound system, ExAblate Neuro, has been awarded the European CE mark for the treatment of neurological disorders in the brain including essential tremor, Parkinson's disease and neuropathic pain.

4 Dec 2012

InSightec receives European CE mark for ExAblate Neuro system

Elbit Imaging Ltd. announced today that on December 3, 2012, Elbit Medical Technologies Ltd., announced that InSightec Ltd. has been awarded the European CE mark for its transcranial focused ultrasound system, ExAblate Neuro, with respect to the treatment of neurological disorders in the brain, including essential tremor, Parkinson's disease and neuropathic pain.

4 Dec 2012

St. Luke's unveils Discovery IGS 730 Hybrid OR from GE Healthcare

St. Luke's University Hospital unveiled the Discovery IGS 730 Hybrid OR from GE Healthcare today, becoming the first hospital in the United States to offer this exciting new technology.

17 Nov 2012

BeamPath ROBOTIC system from OmniGuide used in Laparoscopic Myomectomy

Antonio R. Gargiulo, MD of the Center for Infertility and Reproductive Surgery at Brigham and Women's Hospital completed a live surgery for the American Society of Reproductive Medicine, treating a patient suffering from uterine fibroids with a novel robotic surgical approach and a cutting edge laser technology developed at OmniGuide in Cambridge, MA.

3 Nov 2012

Alternate method to precisely tag breast cancer tumors

When surgeons operate to remove a tumor, determining exactly where to cut can be tricky. Ideally, the entire tumor should be removed while leaving a continuous layer of healthy tissue, but current techniques for locating the tumors during surgery are imprecise. Now a multidisciplinary team from the University of California, San Diego, is developing an alternate means of precisely tagging breast cancer tumors for removal or targeted destruction.

29 Oct 2012

Focused ultrasound technology safe, effective in treating patients with tremor-dominant Parkinson's

The Focused Ultrasound Foundation today announced a new clinical trial investigating the use of focused ultrasound technology in treating patients with tremor-dominant Parkinson's disease.

25 Oct 2012

Genetic basis of uterine fibroids uncovered

A mutation located near the fatty acid synthase gene is associated with an increased predisposition for uterine leiomyomata or fibroids, suggest US study findings.

8 Oct 2012

Researchers identify genetic risk allele for uterine fibroids

Uterine fibroids are the most common type of pelvic tumors in women and are the leading cause of hysterectomy in the United States. Researchers from Brigham and Women's Hospital (BWH) are the first to discover a genetic risk allele (an alternative form of a gene) for uterine fibroids in white women using an unbiased, genome-wide approach.

5 Oct 2012

Prenatal exposure to BPA appears to program uterine estrogen responsiveness in adulthood

Prenatal exposure to bisphenol A, or BPA, a chemical found in many common plastic household items, can cause numerous genes in the uterus to respond differently to estrogen in adulthood, according to a study using a mouse model. The results will be presented Tuesday at The Endocrine Society's 94th Annual Meeting in Houston.

27 Jun 2012

Abbott commences elagolix Phase 3 trial in endometriosis

Abbott, in cooperation with Neurocrine Biosciences, Inc., today announced the initiation of a pivotal Phase 3 clinical trial designed to evaluate the safety and efficacy of elagolix in female patients with endometriosis.

6 Jun 2012

Urocortin 2 improves cardiac output in Phase II study for acute decompensated heart failure

Neurocrine Biosciences, Inc. today announced efficacy and safety results from a Phase II trial of urocortin 2 in 53 patients with acute decompensated heart failure. The UNICORN study was conducted over approximately a two year period by the Cardioendocrine Research Group from the University of Otago in Christchurch, New Zealand and included patients admitted to Christchurch Hospital with acute decompensated heart failure.

18 May 2012

Uterine Fibroids News and Research

Latest Uterine Fibroids News and Research

AMA establishes new CPT code for RF Ablation of Uterine Fibroids

MRIgFU ablation therapy reduces pain in 67% of patients with bone tumors

Non-invasive brain surgery: an interview with Dr Andres Lozano, University of Toronto

Women with sufficient amounts of vitamin D less likely to develop uterine fibroids

Halt Medical reveals initial commercialization results, additional launch plans for Acessa System

Neurocrine Biosciences starts elagolix Phase IIb clinical trial for treatment of uterine fibroids

Neurocrine Biosciences fourth quarter net income increases to $9.5 million

African-American women who reported childhood abuse had greater risk of uterine fibroids

Halt Medical receives $15M financing for commercialization of Acessa uterine fibroid treatment system

EC grants CE mark to InSightec’s ExAblate Neuro ultrasound system

InSightec receives European CE mark for ExAblate Neuro system

St. Luke's unveils Discovery IGS 730 Hybrid OR from GE Healthcare

BeamPath ROBOTIC system from OmniGuide used in Laparoscopic Myomectomy

Alternate method to precisely tag breast cancer tumors

Focused ultrasound technology safe, effective in treating patients with tremor-dominant Parkinson's

Genetic basis of uterine fibroids uncovered

Researchers identify genetic risk allele for uterine fibroids

Prenatal exposure to BPA appears to program uterine estrogen responsiveness in adulthood

Abbott commences elagolix Phase 3 trial in endometriosis

Urocortin 2 improves cardiac output in Phase II study for acute decompensated heart failure

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Uterine Fibroids News and Research

Latest Uterine Fibroids News and Research

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in